All In MedTech

Device Trial Radar · NCT06726343

Maternal Fetal Device Performance Singleton

Maternal Fetal Device Performance Testing During Antepartum Singleton Monitoring

Last checked: Nov 20, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Oct 28, 2024

Primary completion

Dec 23, 2024

Study completion Dec 23, 2024

Sponsor

Lead sponsor
GE HealthcarePublic (GEHC)
Sponsor type
Industry
First posted
Dec 10, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which supports the decision making for pregnant women and the overall fetal health status during pregnancy and delivery. This study aims to support a new maternal fetal monitoring device with clinical data to demonstrate the equivalent performance against the currently marketed Corometrics 259cx. The fetal heart rate and will be collected during antenatal monitoring using standard of care Doppler ultrasound.

Conditions

  • Pregnancy

Interventions

  • Fetal Monitoring DeviceDevice

    Fetal monitoring device is a multi-parameter maternal fetal monitor that is intended to monitor, store, display, transmit, and generate alarms for non-invasive and invasive clinical parameters of pregnant women and fetuses (singleton and twin), during the antepartum, intrapartum, and postpartum period.

  • Investigational Fetal Monitoring DeviceDevice

    Fetal monitoring device is a multi-parameter maternal fetal monitor that is intended to monitor, store, display, transmit, and generate alarms for non-invasive and invasive clinical parameters of pregnant women and fetuses (singleton and twin), during the antepartum, intrapartum, and postpartum period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success Rate Calculated Based on Collection of Fetal Heart Rate Data From Investigational Devices on Subjects Enrolled in Each Gestational Age GroupTime frame: 30 minutes with investigational device over the course of 1 visit.
  2. Success Rate Calculated Based on Collection of Fetal Heart Rate Data From Coro 259cx Devices on Subjects Enrolled in Each Gestational Age GroupTime frame: 30 minutes with Coro 259cx over the course of 1 visit.
  3. Difference in Success Rate Calculated Based on Collection of Fetal Heart Rate Data From Investigational and Coro 259cx Devices on Subjects Enrolled in Each Gestational Age GroupTime frame: 30 minutes with Coro 259cx and 30 minutes of investigational over the course of 1 visit.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Element Materials Technology

    Louisville, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.